SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ABVC

ABVC BioPharma Inc.
NASDAQHealth Care

Latest close: 1.01 USD · Jul 29, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 27, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 12, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 12, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year194
SEC filings on record72916 flagged findings
Reported transactions (Form 4)—not covered
Corporate events (8-K)30since May 23, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-18share offering or dilution eventrecentOpen filing ↗
    “…a new warrant to purchase 1,000,000 shares Common Stock, exercisable at any time on or after the date of its issuance and until…”
    +1 more passage from the same document
    • “…pursuant to which Lind exercised, for cash, 1,000,000 of its Pre-Existing Warrants (all of the warrants issued to Lind on…”
  • 2026-05-18listing compliance noticerecentOpen filing ↗
    “…The notification received has no immediate effect on the listing of the Company’s common stock on Nasdaq. Under the Nasdaq…”
    +1 more passage from the same document
    • “…compliance, it may be subject to delisting. 5 On July 10, 2024, we received a notification letter from the Nasdaq notifying…”
  • 2026-05-18capital return (buybacks/dividends)recentOpen filing ↗
    “…note payable with a principal amount of $ 9,010 to an individual investor, for total consideration of $ 9,010 . The note has a 1…”
    +1 more passage from the same document
    • “…amount of $ 240,000 , $ 100,000 , and $ 150,000 , respectively, for total consideration equal to the principal amounts. These…”
  • 2026-03-03share offering or dilution eventrecentOpen filing ↗
    “…1,000,000 shares Common Stock, exercisable at any time on or after the date of its issuance and until the five-year anniversary…”
    +1 more passage from the same document
    • “…hereinafter referred to as the “Pre-Existing Warrants”) to purchase shares of Common Stock at a reduced exercise price of $0.75 per…”
  • 2026-03-03listing compliance noticerecentOpen filing ↗
    “…except for Nasdaq Listing Rule 5550(a)(2), and provide a written notice of its intention to cure this deficiency during the…”
    +1 more passage from the same document
    • “…the Company written confirmation of compliance. If the Company does not regain compliance during such 180-day period, the…”
  • 2026-03-03export control restrictionsrecentOpen filing ↗
    “…of governmental controls or changes in government regulations, including tax laws, regulations and treaties; ● changes in, or…”
  • 2026-03-03capital return (buybacks/dividends)recentOpen filing ↗
    “…note payable with a principal amount of $ 9,010 to an individual investor, for total consideration of $ 9,010 . The note has a 1…”
    +1 more passage from the same document
    • “…amount of $ 240,000 , $ 100,000 , and $ 150,000 , respectively, for total consideration equal to the principal amounts. These…”
  • 2026-03-03reverse splitrecentOpen filing ↗
    “…Company maintain the quality of the product and lower the cost of raw materials, which in turn will lower the cost of the drug…”
    +1 more passage from the same document
    • “…substance and the drug product when its botanical drugs become commercialized. 47 Common Stock Reverse Split On July 25, 2023, the…”

4 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:10 on Jul 25, 2023) · 1:10 cumulative

The other times: of 768 securities that did their first reverse split in 5 years, a year later the median was worth 0.55× the price on the day of the split; 353 lost more than half and 201 rose (768 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 729)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 29, 26DEF 14A ↗Shareholder meeting and votes
  • Aug 27, 268-K ↗Current report · Completed an acquisition or disposal
  • Aug 17, 26424B4 ↗Securities offering
  • Aug 17, 26424B4 ↗Securities offering
  • Aug 17, 26424B4 ↗Securities offering
  • Aug 17, 26424B4 ↗Securities offering
  • Aug 12, 2610-Q ↗Quarterly report
  • Aug 12, 268-K/A ↗Current report · Other events · amendment
  • Aug 4, 268-K ↗Current report · Other events
  • Jul 28, 26PRE 14A ↗Shareholder meeting and votes
  • Jul 2, 268-K ↗Current report · Auditor change filing (8-K Item 4.01)
  • May 18, 2610-Q ↗Quarterly report
  • May 15, 26NT 10-Q ↗Late filing notice
  • Mar 27, 26POS AM ↗Securities offering
  • Mar 27, 268-K ↗Current report · Shareholder vote results
  • Mar 5, 26DEF 14A ↗Shareholder meeting and votes
  • Mar 3, 2610-K ↗Annual report
  • Mar 3, 2610-Q/A ↗Quarterly report · amendment
  • Mar 3, 268-K ↗Current report · Past accounts declared unreliable and being restated
  • Feb 5, 26PRE 14A ↗Shareholder meeting and votes
  • Jan 16, 268-K/A ↗Current report · Sold unregistered shares · amendment
  • Nov 14, 25424B4 ↗Securities offering
  • Nov 14, 25424B4 ↗Securities offering
  • Nov 14, 25424B4 ↗Securities offering
  • Nov 14, 25424B4 ↗Securities offering

729 filings on record, the oldest from Aug 13, 03.

Listing the 25 most recent filings of the 729 on record.

8-Ks, explained

Stress24Structure190Governance71
  • Aug 27, 26StructureCompleted an acquisition or disposal+3 more in the same filing8-K 2.01 ↗
  • Jul 2, 26GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Mar 3, 26StressPast accounts declared unreliable and being restated+2 more in the same filing8-K 4.02 ↗
  • Jan 16, 26StructureSold unregistered shares+1 more in the same filing8-K/A 3.02 ↗
  • Oct 30, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Sep 12, 25GovernanceAuditor change filing (8-K Item 4.01)8-K/A 4.01 ↗
  • Jul 18, 25StructureEntered a material agreement+2 more in the same filing8-K/A 1.01 ↗
  • May 30, 25StructureSold unregistered shares+1 more in the same filing8-K/A 3.02 ↗
  • May 14, 25StructureSold unregistered shares+1 more in the same filing8-K/A 3.02 ↗
  • May 14, 25StressListing notice (8-K 3.01)+2 more in the same filing8-K/A 3.01 ↗
  • May 6, 25StressListing notice (8-K 3.01)+1 more in the same filing8-K/A 3.01 ↗
  • May 2, 25StressPast accounts declared unreliable and being restated8-K/A 4.02 ↗

13 older filings not shown · The record reaches back to Aug 31, 05.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Apr 30, 25StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Apr 15, 25StressPast accounts declared unreliable and being restated+3 more in the same filing8-K 4.02 ↗
  • Jan 13, 25StressListing notice (8-K 3.01)+2 more in the same filing8-K/A 3.01 ↗
  • Jul 12, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 24, 14StressBankruptcy or receivership proceedings+6 more in the same filing8-K 1.03 ↗
  • Dec 8, 10StressA debt obligation was accelerated8-K 2.04 ↗

The full record holds 24 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Lind Global Fund II LP3.2%Jun 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Its sector and its market

ABVC BioPharma Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From ABVC BioPharma Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow ABVC BioPharma Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
729 documents on file, from Aug 13, 2003 to Sep 29, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.